- Home
- ATO vs DGX Comparison
ATO vs DGX Comparison
Compare ATO & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATO
- DGX
- Stock Information
- Founded
- ATO 1906
- DGX 1967
- Country
- ATO United States
- DGX United States
- Employees
- ATO N/A
- DGX N/A
- Industry
- ATO Oil/Gas Transmission
- DGX Medical Specialities
- Sector
- ATO Utilities
- DGX Health Care
- Exchange
- ATO Nasdaq
- DGX Nasdaq
- Market Cap
- ATO 21.4B
- DGX 19.2B
- IPO Year
- ATO 1987
- DGX 1996
- Fundamental
- Price
- ATO $157.54
- DGX $163.80
- Analyst Decision
- ATO Buy
- DGX Buy
- Analyst Count
- ATO 8
- DGX 14
- Target Price
- ATO $154.79
- DGX $180.36
- AVG Volume (30 Days)
- ATO 1.2M
- DGX 1.5M
- Earning Date
- ATO 05-07-2025
- DGX 04-22-2025
- Dividend Yield
- ATO 2.21%
- DGX 1.95%
- EPS Growth
- ATO 11.40
- DGX 2.67
- EPS
- ATO 7.00
- DGX 7.69
- Revenue
- ATO $4,182,719,000.00
- DGX $9,872,000,000.00
- Revenue This Year
- ATO $13.99
- DGX $10.29
- Revenue Next Year
- ATO $11.75
- DGX $3.98
- P/E Ratio
- ATO $22.50
- DGX $21.30
- Revenue Growth
- ATO 5.90
- DGX 6.70
- 52 Week Low
- ATO $110.97
- DGX $125.42
- 52 Week High
- ATO $159.20
- DGX $178.87
- Technical
- Relative Strength Index (RSI)
- ATO 64.44
- DGX 44.81
- Support Level
- ATO $142.54
- DGX $157.20
- Resistance Level
- ATO $157.62
- DGX $169.69
- Average True Range (ATR)
- ATO 4.41
- DGX 5.65
- MACD
- ATO 0.63
- DGX -0.10
- Stochastic Oscillator
- ATO 90.57
- DGX 39.29
About ATO Atmos Energy Corporation
Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.